K. Rett

4.6k total citations · 1 hit paper
83 papers, 3.4k citations indexed

About

K. Rett is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Molecular Biology. According to data from OpenAlex, K. Rett has authored 83 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Endocrinology, Diabetes and Metabolism, 27 papers in Physiology and 24 papers in Molecular Biology. Recurrent topics in K. Rett's work include Metabolism, Diabetes, and Cancer (18 papers), Diet and metabolism studies (15 papers) and Adipose Tissue and Metabolism (14 papers). K. Rett is often cited by papers focused on Metabolism, Diabetes, and Cancer (18 papers), Diet and metabolism studies (15 papers) and Adipose Tissue and Metabolism (14 papers). K. Rett collaborates with scholars based in Germany, United States and United Kingdom. K. Rett's co-authors include M. Wicklmayr, E. Maerker, W. Renn, G. Dietze, S. Matthäei, Simon N. Jacob, Stephan Jacob, A. Volk, H. Mehnert and Klaus Brechtel and has published in prestigious journals such as Circulation, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

K. Rett

81 papers receiving 3.3k citations

Hit Papers

Association of increased intramyocellular lipid content w... 1999 2026 2008 2017 1999 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Rett Germany 28 1.4k 1.0k 987 858 470 83 3.4k
Stephan Jacob Germany 30 966 0.7× 756 0.7× 1.0k 1.0× 805 0.9× 293 0.6× 70 2.8k
Kaushik Desai Canada 29 1.7k 1.2× 837 0.8× 707 0.7× 844 1.0× 221 0.5× 57 3.7k
Johan Van de Voorde Belgium 27 1.8k 1.3× 1.1k 1.1× 498 0.5× 1.1k 1.3× 261 0.6× 121 4.1k
Keiji Isshiki Japan 38 898 0.6× 698 0.7× 1.1k 1.1× 1.7k 2.0× 923 2.0× 73 5.1k
Nigishi Hotta Japan 28 868 0.6× 431 0.4× 676 0.7× 693 0.8× 237 0.5× 100 3.3k
Nobuo Sakamoto Japan 25 709 0.5× 538 0.5× 502 0.5× 649 0.8× 259 0.6× 153 2.9k
Robert Bergholm Finland 27 977 0.7× 872 0.8× 1.5k 1.5× 770 0.9× 2.2k 4.6× 34 4.0k
Christian Rask‐Madsen United States 31 1.3k 0.9× 986 0.9× 1.1k 1.1× 1.4k 1.7× 918 2.0× 55 4.5k
Pawel M. Kaminski United States 35 2.4k 1.7× 1.3k 1.2× 334 0.3× 1.5k 1.8× 263 0.6× 68 4.9k
Andrea Semplicini Italy 35 758 0.5× 1.1k 1.0× 1.0k 1.0× 1.4k 1.6× 460 1.0× 165 4.0k

Countries citing papers authored by K. Rett

Since Specialization
Citations

This map shows the geographic impact of K. Rett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Rett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Rett more than expected).

Fields of papers citing papers by K. Rett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Rett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Rett. The network helps show where K. Rett may publish in the future.

Co-authorship network of co-authors of K. Rett

This figure shows the co-authorship network connecting the top 25 collaborators of K. Rett. A scholar is included among the top collaborators of K. Rett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Rett. K. Rett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ziegler, Dan, Rüdiger Landgraf, Ralf Lobmann, et al.. (2024). Current Practice of Podiatrists in Testing for Diabetic Polyneuropathy and Implementing Foot Care (PROTECT Study Survey 2). Endocrine Practice. 30(9). 817–821. 1 indexed citations
2.
Ziegler, Dan, Rüdiger Landgraf, Ralf Lobmann, et al.. (2018). Painful and painless neuropathies are distinct and largely undiagnosed entities in subjects participating in an educational initiative (PROTECT study). Diabetes Research and Clinical Practice. 139. 147–154. 52 indexed citations
3.
Ziegler, Dan, Alexander Strom, Ralf Lobmann, et al.. (2015). High prevalence of diagnosed and undiagnosed polyneuropathy in subjects with and without diabetes participating in a nationwide educational initiative (PROTECT study). Journal of Diabetes and its Complications. 29(8). 998–1002. 32 indexed citations
4.
Rett, K., et al.. (2008). Verbesserte Insulinwirkung durch ACE-Hemmung beim Typ-II-Diabetiker*. DMW - Deutsche Medizinische Wochenschrift. 113(7). 243–249. 1 indexed citations
5.
Jacob, Simon N., et al.. (2004). Effects of Moxonidine vs. Metoprolol on Blood Pressure and Metabolic Control in Hypertensive Subjects with Type 2 Diabetes. Experimental and Clinical Endocrinology & Diabetes. 112(6). 315–322. 35 indexed citations
6.
Jacob, Simon N., Michael Stümvoll, Roland Becker, et al.. (2000). The PPARγ2 Polymorphism Pro12Ala is Associated with Better Insulin Sensitivity in the Offspring of Type 2 Diabetic Patients. Hormone and Metabolic Research. 32(10). 413–416. 51 indexed citations
7.
Jacob, Stephan, Roland Becker, W. Renn, et al.. (1999). Lipolysis in skeletal muscle is rapidly regulated by low physiological doses of insulin. Diabetologia. 42(10). 1171–1174. 35 indexed citations
8.
Camastra, Stefania, et al.. (1999). Effect of obesity and insulin resistance on resting and glucose-induced thermogenesis in man. International Journal of Obesity. 23(12). 1307–1313. 53 indexed citations
9.
Rett, K., et al.. (1997). Perfusion-Independent Effect of Bradykinin and Fosinoprilate on Glucose Transport in Langendorff Rat Hearts. The American Journal of Cardiology. 80(3). 143A–147A. 14 indexed citations
10.
Jacob, Stephan, et al.. (1996). Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study.. PubMed. 14(4). 489–94. 184 indexed citations
11.
Wicklmayr, M., K. Rett, & Eberhard Standl. (1994). [How can primary prevention of coronary heart disease be improved in general practice?].. PubMed. 89(4). 184–6, 229. 1 indexed citations
12.
Rett, K., Stephan Jacob, & M. Wicklmayr. (1994). Possible Synergistic Effect of ACE Inhibition and Calcium-Channel Blockade on Insulin Sensitivity in Insulin-Resistant Type II Diabetic Hypertensive Patients. Journal of Cardiovascular Pharmacology. 23(Supplement 1). S29–S33. 6 indexed citations
14.
Wicklmayr, M., et al.. (1989). Bradykinin is not Liberated by Working Skeletal Muscle in Diabetes Type II. Hormone and Metabolic Research. 21(4). 222–223. 4 indexed citations
15.
Rett, K., et al.. (1988). [Inhibition of muscle amino acid release by infusion of a triglyceride emulsion].. PubMed. 15(2). 78–82. 1 indexed citations
16.
Wicklmayr, M., K. Rett, G. Dietze, & H Mehnert. (1988). Comparison of Metabolic Clearance Rates of MCT/LCT and LCT Emulsions in Diabetics. Journal of Parenteral and Enteral Nutrition. 12(1). 68–71. 30 indexed citations
17.
Rett, K., et al.. (1988). Inhibition of Muscular Ketone Extraction by Lipid Infusion in Man. Hormone and Metabolic Research. 20(8). 502–505. 4 indexed citations
18.
Jauch, K.‐W., et al.. (1987). Captopril enhances insulin responsiveness of forearm muscle tissue in non‐insulin‐dependent diabetes mellitus. European Journal of Clinical Investigation. 17(5). 448–454. 130 indexed citations
19.
Rett, K., et al.. (1986). Effects of Kallikrein (K), Bradykinin (B) and Insulin (I), on Substrate Metabolism in the Isolated Perfused Rat Heart. Advances in experimental medicine and biology. 198 Pt B. 379–384. 5 indexed citations
20.
Wicklmayr, M., G. Dietze, K. Rett, & H. Mehnert. (1985). Evidence for a Substrate Regulation of Triglyceride Lipolysis in Human Skeletal Muscle. Hormone and Metabolic Research. 17(9). 471–475. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026